Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3 clinical trial of aficamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy (HCM).

The National Academies of Sciences, Engineering, and Medicine (NASEM) has [...]

The Association of Black Cardiologists (ABC) is proud to highlight [...]

From March 27–30, 2026, the Association of Black Cardiologists [...]

The Association of Black Cardiologists (ABC) joined bipartisan members of [...]

The ABC is pleased to announce the availability of [...]